Drug Shortage Report for PRIORIX-TETRA

Last updated on 2019-05-23 History
Report ID 82768
Drug Identification Number 02297884
Brand name PRIORIX-TETRA
Common or Proper name Combined measles, mumps, rubella and varicella vaccine, live, attenuated
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s) 25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR SUBCUTANEOUS
Packaging size 10's
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-04-24
Estimated end date 2019-07-12
Actual end date
Shortage status Actual shortage
Updated date 2019-05-23
Company comments Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-05-23 French Compare
v3 2019-05-23 English Compare
v2 2019-04-29 French Compare
v1 2019-04-29 English Compare